Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome
Clinical trial NCT00138723 · COMPLETED
Trial details
- NCT number
- NCT00138723
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2005-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.